Login
$SPTX
$19.12 -$0.86 (4.3%) Live

$SPTX SEC Filings

Filed On Filing
13 Nov 2026 Form 4: Zohar Daphne, Director

Gave 100,000 shares as a gift

04 Nov 2026 Form 4: Torres Denice, Director

Bought 5,000 shares ($99.3K)

02 Nov 2026 10-Q
02 Nov 2026 8-K: Results of Operations and Financial Condition

Announced positive topline data from Phase 1 driving simulation trial of GlyphAlloTM, showing that GlyphAllo did not impair next-morning driving performance compared to placebo

14 Aug 2026 SCHEDULE 13G
05 Aug 2026 SCHEDULE 13G
05 Aug 2026 SCHEDULE 13G
03 Aug 2026 10-Q
03 Aug 2026 8-K: Results of Operations and Financial Condition

Enrollment in Phase 2b BUOY-1 trial of GlyphAlloTM in major depressive disorder (MDD) is on track with topline data expected in 1H 2027

24 Jun 2026 Form 4: Hombach Robert J., Director

Bought 13,000 shares ($236K)

08 Jun 2026 10-Q
08 Jun 2026 8-K: Results of Operations and Financial Condition

New data from Phase 1 trial of GlyphAgoTM build upon previously reported topline data and further demonstrate GlyphAgoTM can achieve therapeutic exposures of agomelatine at doses projected to avoid liver enzyme elevations and reduce or e...

11 May 2026 SCHEDULE 13D
11 May 2026 SCHEDULE 13G
06 May 2026 Form 3: Gap Coinvestments CDA, L.p., Director and 3 others

Holds 6,101,582 shares of Common Stock, par value $0.0001 per share ("Common Stock")

06 May 2026 Form 3: General Atlantic (SP), L.p., Director and 9 others

Holds 6,101,582 shares of Common Stock, par value $0.0001 per share ("Common Stock")

06 May 2026 Form 4: PureTech Health plc, 10% owner and 1 other

Received 16,382,534 shares by conversion

06 May 2026 SCHEDULE 13D
04 May 2026 Form 4: Zohar Daphne, Director

Granted 1,758,599 Stock Option (Right to Buy)

04 May 2026 Form 4: White Lauren, Chief Financial Officer

Granted 63,680 Stock Option (Right to Buy) · Received 6,702 shares by conversion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support